Brief: Lineage Initiates Clinical Study Of OPC1 For Spinal Cord Injury
Feb 11 (Reuters) - Lineage Cell Therapeutics LCTX.A :
* LINEAGE INITIATES CLINICAL STUDY OF OPC1 FOR SPINAL CORD
INJURY
Source text: ID:nBw9Th3h0a
Further company coverage: LCTX.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lineage Cell Therapeutics
See all newsLineage Cell Therapeutics Q2 revenue falls but posts profit
Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million
Lineage Cell Therapeutics Q1 net loss widens as expenses rise
Lineage Cell Q4 revenue rises on Genentech collaboration
Brief: Lineage Cell Therapeutics FY Income From Operations USD -36.619 Million